These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 10564073

  • 21. A process analytical technology approach based on near infrared spectroscopy: tablet hardness, content uniformity, and dissolution test measurements of intact tablets.
    Blanco M, Alcalá M, González JM, Torras E.
    J Pharm Sci; 2006 Oct; 95(10):2137-44. PubMed ID: 16883562
    [Abstract] [Full Text] [Related]

  • 22. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N, Elkordy AA.
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [Abstract] [Full Text] [Related]

  • 23. Controlled precipitation for enhanced dissolution rate of flurbiprofen: development of rapidly disintegrating tablets.
    Essa EA, Elmarakby AO, Donia AMA, El Maghraby GM.
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1430-1439. PubMed ID: 28402193
    [Abstract] [Full Text] [Related]

  • 24. Clarification of the internal structure and factors of poor dissolution of substandard roxithromycin tablets by near-infrared chemical imaging.
    Sakuda M, Yoshida N, Koide T, Keila T, Kimura K, Tsuboi H.
    Int J Pharm; 2021 Mar 01; 596():120232. PubMed ID: 33484929
    [Abstract] [Full Text] [Related]

  • 25. Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation.
    Rahman Z, Zidan AS, Khan MA.
    Int J Pharm; 2010 Nov 15; 400(1-2):49-58. PubMed ID: 20801200
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.
    Arafa MF, El-Gizawy SA, Osman MA, El Maghraby GM.
    Pharm Dev Technol; 2018 Jun 15; 23(5):454-463. PubMed ID: 27681386
    [Abstract] [Full Text] [Related]

  • 28. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.
    Hughey JR, Keen JM, Miller DA, Kolter K, Langley N, McGinity JW.
    Eur J Pharm Sci; 2013 Mar 12; 48(4-5):758-66. PubMed ID: 23348153
    [Abstract] [Full Text] [Related]

  • 29. Non-destructive prediction of enteric coating layer thickness and drug dissolution rate by near-infrared spectroscopy and X-ray computed tomography.
    Ariyasu A, Hattori Y, Otsuka M.
    Int J Pharm; 2017 Jun 15; 525(1):282-290. PubMed ID: 28396246
    [Abstract] [Full Text] [Related]

  • 30. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA.
    Int J Pharm; 2016 Feb 29; 499(1-2):20-28. PubMed ID: 26688036
    [Abstract] [Full Text] [Related]

  • 31. Formulation development and in vitro evaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium.
    Ali KA, Mukherjee B, Bandyopadhyay AK.
    Drug Dev Ind Pharm; 2013 Nov 29; 39(11):1742-9. PubMed ID: 23216220
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
    Ojarinta R, Saarinen J, Strachan CJ, Korhonen O, Laitinen R.
    Eur J Pharm Biopharm; 2018 Nov 29; 132():112-126. PubMed ID: 30248394
    [Abstract] [Full Text] [Related]

  • 34. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
    Tabasi SH, Moolchandani V, Fahmy R, Hoag SW.
    Int J Pharm; 2009 Dec 01; 382(1-2):1-6. PubMed ID: 19660535
    [Abstract] [Full Text] [Related]

  • 35. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V, Khanna A, Venkatpurwar V, Dhar S, Mandpe L.
    Acta Pharm; 2009 Jun 01; 59(2):121-32. PubMed ID: 19564138
    [Abstract] [Full Text] [Related]

  • 36. Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation.
    Rahman Z, Siddiqui A, Khan MA.
    Eur J Pharm Biopharm; 2013 Nov 01; 85(3 Pt B):1300-9. PubMed ID: 23800704
    [Abstract] [Full Text] [Related]

  • 37. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W, Ni R, Zhang X, Li LC, Mao S.
    Drug Dev Ind Pharm; 2015 Jun 01; 41(6):927-33. PubMed ID: 24785575
    [Abstract] [Full Text] [Related]

  • 38. pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations.
    Riis T, Bauer-Brandl A, Wagner T, Kranz H.
    Eur J Pharm Biopharm; 2007 Jan 01; 65(1):78-84. PubMed ID: 16919924
    [Abstract] [Full Text] [Related]

  • 39. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
    Gundogdu E, Koksal C, Karasulu E.
    Drug Dev Ind Pharm; 2012 Jun 01; 38(6):689-96. PubMed ID: 22010782
    [Abstract] [Full Text] [Related]

  • 40. Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution.
    Gordon MS, Chowhan ZT.
    J Pharm Sci; 1987 Dec 01; 76(12):907-9. PubMed ID: 3440935
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.